Absci Corp

ABSI Nasdaq SEC CIK 1672688
Follow Absci Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $304K −19.6% vs same quarter last year
Net income −$33.3M −16% vs same quarter last year
EPS, diluted −$0.19 +5% vs same quarter last year
Operating cash flow −$29.5M −17.7% vs same quarter last year
Revenue by quarter
$665K
$1.2M
$593K
$378K
$650K
$215K
$318K
$304K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$2.8M−$115.2M
FY24$4.5M−$103.1M
FY23$5.7M−$110.6M
FY22$5.7M−$104.9M
FY21$4.8M−$101M
FY20$4.8M−$14.4M
FY19--
MarginsShare of revenue
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−4297%−4113.7%
FY24−2401.6%−2274.1%
FY23−2020.2%−1933.6%
FY22−1857.5%−1825.4%
FY21−1573.4%−2111.3%
FY20−278.3%−300.3%
FY19--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$94M
FY24−$72.8M
FY23−$65.5M
FY22−$97.5M
FY21−$98.6M
FY20−$13.2M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Absci
  • Healthcare median
−6000%−4000%−2000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearAbsciHealthcare median
FY25−4113.7%−30.6%
FY24−2274.1%−47%
FY23−1933.6%−58%
FY22−1825.4%−80.4%
FY21−2111.3%−71.9%
FY20−300.3%−62.2%
FY19-−46.3%